Meanwhile, the Centre has stated that pregnant and lactating women have not been part of any Covid vaccine clinical trial so far and should not receive the vaccine at this time.
Baby Harvesting/trafficking: Time For National Dialogue And Collective Action-Rise-Ghana
By RISE Ghana Listen to article
Globally, an estimated 580 (approximately 5-8% of couples) million people experience infertility, with more than half, 372 million in lower and middle-income countries (WHO, 2004). Africa has the largest burden of 10-32% of infertile couples (Okonofua, 2005).
On 20
th January 2021, the Ghana Medical Council (MDC) and the Economic and Organized Crime Office (EOCO) issued a joint statement about the involvement of some medical practitioners, social welfare officers and individuals in what appears to be a complicated syndicate involving baby harvesting and baby selling using trusted government facilities and departments like hospitals and the department of social welfare as a conduit. The disturbing news flooded the nation’s traditional and new media as Ghanaian expressed their shock.
A fertility specialist and gynecologist, Dr Kunle Ajayi, has admonished Nigerian couples that are challenged by infertility to desist from patronising baby factories and other illegal institutions in their own interest
Surrogacy was trending big as a topic for discussion on social networking sites recently after news of an entertainment star having two kids through surrogacy but refusing to raise them went viral.
INVO Bioscience Advances Commercialization into the European Fertility Market with Initial Orders of INVOcell (IVC) in Spain
- Spain marks INVO s initial entry into the European market
- Europe represents approximately 30% of the multi-billion dollar global fertility marketplace
- The first three clinics in Spain have placed initial orders for INVOcell - an effective and affordable alternative treatment for patients diagnosed with infertility
News provided by
Share this article
SARASOTA, Fla., Jan. 27, 2021 /PRNewswire/
INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world s only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, today announced it has advanced its commercialization efforts into the European fertility market by securing initial orders of INVOcell in Madrid and Barcelona, Spain. INVOcell will initially be available at three separ